ArticleIranian journal of public health2025
Population Forecasting with Alzheimer's Disease in Iran Using a System Dynamic Model.
Article in Iranian journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gastric Cancer Incidence in Iran: Trends and Projections to 2030 based on Global Burden of Disease 2021 Estimates.Journal of gastrointestinal cancer · 2026Article
- Public Willingness to Pay for Alzheimer's Preventive Medication in Iran: A Contingent Valuation Study.Risk management and healthcare policy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prevalence of Alzheimer's disease in Iran, attributed to the demographic shift towards an aging population, holds considerable importance. We aimed to estimate the prevalence and number of Alzheimer's disease in Iran by 2029. Methods: Dynamic modeling techniques were employed to project the number of Alzheimer's disease (AD) among the elderly population in Iran by the year 2029. Two interconnected models were developed to facilitate this estimation. The initial model is a demographic model that captures the aging population's growth dynamics. The subsequent model, an AD evaluation model, that assess potential impacts on disease. This approach enables a comprehensive analysis of the factors influencing AD trends within the context of Iran's aging demographic. Results: The results show the number of individuals aged over 60 is expected to rise from approximately 9.1 million in 2020 to around 13.7 million in 2029. As the older adult population grows, the number of AD is also anticipated to increase. The number of Alzheimer's patients is predicted to grow from about 464,400 in 2020 to roughly 729,900 by 2029. Conclusion: Forecasting future trends in AD, especially in developing countries, is crucial for policymakers because of its growing impact on healthcare systems and economies globally. The findings of this study can aid in assessing the economic burdens associated with treating Alzheimer's patients, providing valuable insights for planning and resource allocation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.